DXCM vs PFE
Dexcom vs Pfizer Inc. — AI-powered side-by-side comparison
| Metric | DXCM | PFE |
|---|---|---|
| AI Score | 58 | 58 |
| Price | $71.44 | $24.83 |
| P/E Ratio | 31.15× | 19.04× |
| ROE | 0.3% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.6% | 0.7% |
| Debt / Equity | 0.47× | 0.72× |
| Dividend Yield | 0.0% | 0.1% |
| RSI (14) | 52.3 | 57.8 |
| Beta | 1.453 | 0.307 |
| Expected Upside | +1.6% | +4.5% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
DXCM Full Analysis
PFE Full Analysis